How should I use Truseltiq(Infigratinib)?

The recommended dosage is 125 mg taken orally once daily for 21 consecutive days followed by a 7-day treatment-free period in 28-day cycles.

Dosage and Administration

The standard dosing regimen involves a 125 mg oral dose, taken once daily for 21 days, followed by 7 days off treatment, constituting a complete 28-day cycle. Administration must occur on an empty stomach, at least one hour before or two hours after food, and capsules should be swallowed whole with water. Dose adjustments are necessary for patients with mild to moderate renal impairment (100 mg daily) or mild (100 mg daily) to moderate (75 mg daily) hepatic impairment. Treatment continues until disease progression or unacceptable toxicity occurs.

Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements.
RELATED ARTICLES
/ 0
0 in total
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved